ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
澳股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
MESOBLAST LTD
2.350
0.000
成交量:
178.68萬
成交額:
418.62萬
市值:
30.48億
市盈率:
-22.85
高:
2.370
開:
2.350
低:
2.290
收:
2.350
52周最高:
3.310
52周最低:
1.880
股本:
12.97億
流通股本:
7.86億
量比:
0.62
換手率:
0.23%
股息:
- -
股息率:
- -
每股收益(TTM):
-0.103
每股收益(LYR):
-0.118
淨資產收益率:
-18.22%
總資產收益率:
-6.16%
市淨率:
3.79
市盈率(LYR):
-19.88
資料載入中...
總覽
公司
新聞資訊
公告
概念
新冠治療股
+2.33%
醫藥生物股
+2.85%
資金流向
資金流入:
資金流出:
實時
日
周
月
季度
年
新聞資訊
Mesoblast完成慢性腰痛關鍵性3期試驗患者治療,達成重大里程碑
美股速递
·
08/17
Mesoblast報告Ryoncil®季度淨營收3600萬美元,產品上市首年淨營收達1.15億美元
美股速递
·
07/30
Mesoblast首席執行官增持股份以強化股權
投资观察
·
07/21
異動解讀 | Mesoblast公布Ryoncil收入強勁,股價盤中大漲5%
异动解读
·
07/10
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/hant/stock/MSB.AU"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MSB.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MSB.AU\",,,,,undefined,":{"symbol":"MSB.AU","market":"AU","secType":"STK","nameCN":"MESOBLAST LTD","latestPrice":2.35,"timestamp":1787638320000,"preClose":2.35,"halted":0,"volume":1786763,"delay":0,"changeRate":0,"nameEN":"MESOBLAST LTD","floatShares":786490638,"shares":1296862776,"eps":-0.10283367315424141,"marketStatus":"未開盤","change":0,"latestTime":"08-25 16:12:00 AEST","open":2.35,"high":2.37,"low":2.29,"amount":4186242,"amplitude":0.034043,"askPrice":2.37,"askSize":33951,"bidPrice":2.35,"bidSize":6275,"shortable":3,"etf":0,"ttmEps":-0.10283367315424141,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1787702400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":2.35,"openAndCloseTimeList":[[1787616000000,1787637600000]],"volumeRatio":0.615374,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"MSB.AU","preClose":2.35,"auctionPrice":2.35,"auctionVolume":431775,"auction":3,"marketStatus":"盘后竞价","timestamp":1787638203503}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MSB.AU\",,,,,undefined,":{"symbol":"MSB.AU","floatShares":786490638,"roa":"-6.16%","roe":"-18.22%","lyrEps":-0.118184,"volumeRatio":0.615374,"shares":1296862776,"dividePrice":0,"high":2.37,"amplitude":0.034043,"preClose":2.35,"low":2.29,"week52Low":1.88,"pbRate":"3.79","psRate":"33.35","week52High":3.31,"institutionHeld":0,"latestPrice":2.35,"committee":-0.688013,"eps":-0.10283367315424141,"divideRate":0,"volume":1786763,"delay":0,"ttmEps":-0.10283367315424141,"open":2.35,"prevYearClose":2.72,"prevWeekClose":2.36,"prevMonthClose":2.05,"prevQuarterClose":1.955,"fiveDayClose":2.4,"twentyDayClose":2.06,"sixtyDayClose":2.11,"earningDate":1787760000000,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MSB.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-26","symbol":"MSB.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787702400000,"name":null,"time":"","dateTimestamp":1787666400000,"actualEps":null},{"date":"2025-02-26","symbol":"MSB.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MSB.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MSB.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1176396021","title":"Mesoblast完成慢性腰痛關鍵性3期試驗患者治療,達成重大里程碑","url":"https://stock-news.laohu8.com/highlight/detail?id=1176396021","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176396021?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 08:36","pubTimestamp":1786926968,"startTime":"0","endTime":"0","summary":"Mesoblast(MESOBLAST LTD)在治疗慢性腰痛的关键性3期临床试验中,已顺利完成全部患者的治疗工作。这一成就标志着该公司在推进这一潜在疗法上迈出了决定性的一步。临床试验的完成,不仅为后续的数据分析铺平了道路,也极大地提振了市场对这款创新疗法的信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","MSB.AU","BK7501","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134208248","title":"Mesoblast報告Ryoncil®季度淨營收3600萬美元,產品上市首年淨營收達1.15億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1134208248","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134208248?lang=zh_tw&edition=fundamental","pubTime":"2026-07-30 08:59","pubTimestamp":1785373168,"startTime":"0","endTime":"0","summary":"Mesoblast(股票代码:MSB.AU)公布了其核心产品Ryoncil®的财务表现。数据显示,该公司在最近一个季度录得净营收3600万美元(约合3600万美元)。不仅如此,从产品正式上市至今的第一个完整财年内,Ryoncil®累计贡献的净营收总额已达到1.15亿美元。这一成绩标志着该产品在商业化初期便展现出强劲的市场接纳度与增长潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7067","BK7501","MSB.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157804936","title":"Mesoblast首席執行官增持股份以強化股權","url":"https://stock-news.laohu8.com/highlight/detail?id=1157804936","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157804936?lang=zh_tw&edition=fundamental","pubTime":"2026-07-21 09:53","pubTimestamp":1784598831,"startTime":"0","endTime":"0","summary":"Mesoblast Ltd宣布,其首席执行官已通过投资进一步增持公司股份。具体而言,该首席执行官行使了190万份股票期权,行权价为每股1.45澳元,总价值达273万澳元。此次交易后,其持股总数增加至8080万股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","MSB.AU","BK7508","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110478122","title":"異動解讀 | Mesoblast公布Ryoncil收入強勁,股價盤中大漲5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1110478122","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110478122?lang=zh_tw&edition=fundamental","pubTime":"2026-07-10 11:14","pubTimestamp":1783653296,"startTime":"0","endTime":"0","summary":"Mesoblast Ltd(MSB.AU)今日盘中大涨5.00%,引起了市场的广泛关注。消息面上,Mesoblast Ltd报告称,其产品Ryoncil在第四季度实现净收入3600万美元,全年累计净收入达到1.15亿美元,这一积极的财务表现增强了投资者对公司业务前景的信心。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MSB.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":4,"pageCount":1,"totalSize":14,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/MSB.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"新冠治療股","id":"package_au_concept_xgzlg","bkCode":"BK7501","changeRate":0.023275},{"market":"AU","name":"醫藥生物股","id":"package_au_concept_yyswg","bkCode":"BK7508","changeRate":0.0285}]}}